Dr. John Cullity heads Sanofi Aventis' US Strategic Pricing operations.  

He has been in the pharmaceutical industry for 6 years during which he has directed the pricing strategy for brands such as Ambien, Allegra, Plavix, Lovenox, Eloxatin, Taxotere, Clarinex and Zetia / Vytorin. In addition to the support of in-market products, John has a particular interest in working with new product and business development teams leading to the identification of optimal price points for pre-launch and buy-side opportunities.

Prior to joining Sanofi, John was employed at Schering Plough where he founded the Strategic Pricing unit and directed oncology and allergy health economics. He has also worked for AT Kearney Management Consulting, The World Bank and WHO.

He holds an MBA from Wharton Business School, University of Pennsylvania, MSc (Econs) from London School of Economics, Medical specialist degree from the Royal College of Physicians, UK and Medical degree from University of Western Australia.